FDA Announces Nationwide Recall of More Than 4 Million Tubes of Toothpaste

관련 기사

1. 10.21Samsung Bioepis' first ADC candidate wins FDA Fast TrackThe Korea Herald
2. 10.21Samsung Bioepis wins FDA Fast Track for 1st anticancer drug candidateThe Korea Times
3. 10.21Samsung Bioepis' First Novel Drug Candidate SBE303 Wins FDA Fast Track DesignationBigGo Finance
4. 10.21Samsung Bioepis Receives FDA Fast Track Designation for SBE303Businesskorea
5. 10.21삼성바이오에피스, '1호 신약' 미국 FDA 패스트트랙 지정데일리팜
6. 10.21삼성바이오에피스 "1호 신약후보 미국 FDA 패스트트랙 지정"연합뉴스
7. 10.21삼성바이오에피스, 'SBE303' 미국 FDA 패스트 트랙 의약품 지정히트뉴스
8. 10.21Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugsUSA Today
9. 10.21GLP-1 injections recalled nationwide over sterility concerns, FDA saysFox Business
10. 10.20메디쎄이, 올해 미국 FDA 510(k) '3연속 인증' 척추 시장 정조준약사공론